248 results
6-K
EX-99.1
MOR
Morphosys AG
29 Apr 24
Current report (foreign)
4:15pm
with cancer. As a global biopharmaceutical company, we develop and deliver innovative medicines, aspiring to redefine how cancer is treated. MorphoSys
6-K
EX-99.1
MOR
Morphosys AG
24 Apr 24
Current report (foreign)
11:03am
biopharmaceutical company, we develop and deliver innovative medicines, aspiring to redefine how cancer is treated. MorphoSys is headquartered in Planegg
SC 14D9
EX-99
MOR
Morphosys AG
11 Apr 24
Tender offer solicitation
11:57am
for people with cancer. As a global biopharmaceutical company, we develop and deliver innovative medicines, aspiring to redefine how cancer is treated
SC 14D9
EX-99
MOR
Morphosys AG
11 Apr 24
Tender offer solicitation
11:57am
Business Activities
MorphoSys is a global biotechnology company focused on the development and commercialization of innovative cancer medicines … is focused on the development and commercialization of innovative cancer medicines, advancing its mid-to-late-stage oncology pipeline in areas where
SC TO-T
EX-99
MOR
Morphosys AG
11 Apr 24
Third party tender offer statement
6:01am
in the healthcare industry and will bring a wealth of experience in leadership, strategy, business development and commercialization of innovative … , manufacturing, distribution, and commercialization and sale of innovative medicines, with a focus on four core therapeutic areas: cardiovascular, renal
SC TO-T
EX-99
90zn81y
11 Apr 24
Third party tender offer statement
6:01am
SC14D9C
EX-99.1
6yc70hz0rpxvzmu
22 Mar 24
Written communication relating to third party tender offer
4:45pm
6-K
EX-99.1
ui7wgjqvr w0
22 Mar 24
Current report (foreign)
6:47am
6-K
EX-99.1
s7h28b30v8
20 Mar 24
Current report (foreign)
4:12pm
SC14D9C
EX-99.1
grk6 jxcb
14 Mar 24
Written communication relating to third party tender offer
4:52pm
6-K
EX-99.1
owa9u 0bds
14 Mar 24
Current report (foreign)
8:27am
SC14D9C
EX-99.1
f6l3tqn02jn 71b
13 Mar 24
Written communication relating to third party tender offer
5:22pm
SC14D9C
EX-99.4
e2gbbs ttgzh7e7y
13 Mar 24
Written communication relating to third party tender offer
5:22pm
6-K
EX-99.1
up1p4gg1owsbz0gk8ipr
13 Mar 24
Non-Financial Group Report 2023
4:12pm
6-K
EX-99.1
zq9l0i1 ai
13 Mar 24
Current report (foreign)
4:08pm
6-K
EX-99.1
a1fj3 k21
11 Mar 24
Current report (foreign)
7:05am
6-K
EX-99.1
h3obuzdrv
7 Feb 24
MorphoSys Enters into Business Combination Agreement to be
6:57am
6-K
EX-99.2
zyewkc0
7 Feb 24
MorphoSys Enters into Business Combination Agreement to be
6:57am
SC14D9C
EX-99.4
s9bou852ofh86eq0gf
6 Feb 24
Written communication relating to third party tender offer
4:58pm